Executive Director, Business Development, Seattle Genetics
Neela Patel joined Seattle Genetics as Exec Director Business Development in May 2016, with responsibility for identification, evaluation, and transaction of collaboration, licensing, and acquisition opportunities to diversify the pipeline. Previously, at AbbVie she identified, introduced, and led technical diligence, resulting in more than twenty five executed deals including collaborations, licensing, and participation in consortia. Dr. Patel spent the first 16 years of her career in drug discovery management positions of increasing responsibility to advance small molecules and biologics from early stage discovery through IND filing at Poniard Pharmaceuticals, Genentech, SUGEN/Pharmacia, and Roche Bioscience. Dr. Patel was also a key member of several start-up company teams that established the overall business and scientific strategies, and successfully secured funding.